Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The Opioids Market has demonstrated several key trends and volatile shifts that reflect a dynamic networking of multiple healthcare, regulatory, and societal segments. There is a distinct trend of enhancing supervision and regulation of opioid prescriptions in one of these aspects. With increasing fears about opioid addictions and abuse, the regulatory power and health care professionals are now below strict procedures and supervision mechanisms to limit the overprescription of opioids. This tendency reflects not only the growing understanding of the opioid epidemic but also the realization that adequate health care system to address the public health ramifications of opioid usage is a priority.
In addition to that, the market is also experiencing the trend where safeguard or abuse-deterring formulations of opioids are being invented and adopted. Through these formulations it is made hardest job for a person to adulterate the medication for recreation and thus reduces the risk of misuse and different kind of addiction. Pharmaceutical companies are funding research and development to advance the formulation of opioids having an upper hand on the safety measure. This way, the healthcare industry will be on a balanced path of managing pain while, at the same time, reducing the potential for abuse.
Moreover, in medicine, there is a developing trend towards non-pharmacological methods of pain management that is largely motivated by a desire to diminish the rates of opioid use for pain relief. There is a surge in the use of alternative, non-opioid analgesics, physical therapy, and non-pharmacological measures as healthcare professionals seek to employ multi-dimensional functional treatment of pain. This trend, exemplifies a growing understanding that pain should be addressed in a whole manner, eliminating opioid risks when possible.
The opioid industry is also issue by the escalation of medication-assisted treatment (MAT) for the opioid use disorder. MAT includes medication-based approaches, e.g. buprenorphine, methadone, and naltrexone in conjunction with counseling and behavioral interventions for opioid addiction. The growing recognition and appreciation of the MAT technique within the health care field could be regarded as one of the positive trends in a fight against opioid dependency and better treatment results.
Additionally, there is the increased attention on public education and media campaigns with the aim of informing health practitioners and the general public on the hazards linked to opioid abuse. These campaigns are intended to encourage responsible prescription practices, create awareness of the symptoms of opioid abuse and provide information on the treatment options readily available to the general public. The public health interventions are central to changing the social dysfunction toward opiates and infusing informed thinking about the pain management.
Covered Aspects:
| Report Attribute/Metric | Details |
|---|---|
| Market Opportunities | Increase of opioid analgesic consumption in all regions and new strategies to combat side effects and slow down the negative effect, through opioid-tolerant drugs |
Opioids Market Highlights:
Opioids Market Overview
The opioids market size is expected to reach USD 6.93 billion at CAGR of 5.4% during the forecast period 2023-2032. Opioids interact with the opioid receptors in the nervous system and decrease the pain of treatments and injuries. With its help, the other parts of the body are blocked from reaching pain signals. Health professionals, patients, and others opt and recommend opioids due to their reasonable cost and availability.
Cancer, lower back pain, and many other treatment pains are reduced by opioids hence considered as an effective solution for such health conditions. The orthopedic market is increasing due to the rise in orthopedic diseases and acute pain. Additionally, the aging and elderly population at a global level have projected an improvement in disposable income. The growth of opioid analgesics is expected to rise during the forecasted time frame due to the vast increase in the market in several countries.
The increase in ailments including cancer, lung infections, HIV, and a few others has fueled the growth of the opioids industry. In the past, it led to an increase in opioid demand and increased growth. The expansion in surgical procedures is another element driving the demand for opioid drugs.
In order to tackle the opioid crisis, specific tactics for abuse-deterrent formulations (ADFs) were developed, leading to an increase in research and development of Vivo/Vitro efficacy. As a result, the rise that raises the anticipated number of opioid market participants would be advantageous for the opioid industry. Additionally, the market growth rates for opioids may significantly accelerate with the development of novel methods to manage side effects and reduce the negative impact through opioid-tolerant medications. There will be many more potential for future development as the usage of opioid analgesics rises across the board.
Due to a rise in demand for the best solutions to treat pain, cough, and diarrhea, the opioids market is predicted to increase significantly throughout the projected period. Increased use of these painkillers and an increase in the elderly population, which is particularly vulnerable to orthopedic pain, are the main drivers driving the market's expansion. Additionally, there has been a marked increase in the number of persons worldwide who have chronic pain. The worldwide opioid industry is expected to rise as a result, according to predictions.
COVID 19 Analysis
Opioids are one such market that has a positive effect on the COVID 19 as it acts as a pain-reducing agent. Also, a large number of the population started to accumulate and save opioids medicine due to government restrictions. During the pandemic, the market grew because of increased health concerns, rising chronic diseases, and growing demand for opioids. The opioids market is estimated to grow significantly and have a huge effect during the COVID 19 era.
Opioids Market Trends
Drivers
Cancer, lung infection, HIV, and some other diseases are on the rise which has driven the expansion of the opioids market growth. In the past, it resulted in a demand surge for opioids and boosted growth. Another factor for the growth of the opioids drug market is the spike in the number of surgeries.
In 2018 the US market saw an upward trend of cosmetic surgical procedures of up to 1.8 million. The forecast year shows a notable increase in surgeries, drug approvals, chronic disease treatment awareness, research initiatives, and others leading to an estimation of the growth of the opioids market.
Restraints
However if not used correctly then the opioid drugs can have major side effects including constipation, sedation, urinary retention, falls, vomiting, nausea, and others. The forecasted period illustrates a decrease in the opioid market growth due to the adversities and the negative effects of opioids. Due to a drug overdose in the year 2018, 657 deaths were on record. Researchers and experts have considered this and are making constant efforts to reduce and minimize the negative and side effects of opioids.
Opportunities
Special strategies for abuse-deterrent formulations (ADFs) were designed to combat the opioid epidemic which increased research and development of Vivo/Vitro effectiveness. The opioid market thus stands to benefit from the growth leading to an increase in the expected opioid market players. Also, with the new strategies to combat side effects and slow down the negative effect, through opioid-tolerant drugs, the opioids market growth rates can show a significant increase. With the increase of opioid analgesic consumption in all regions, there will be a lot more opportunities in the future for further growth.
Challenges
Many challenges can slow the progress of the opioids market, even though it is expected to grow in the forecast period. There is an increase in opioid side effects, overdoses, and misuse. There are not enough funders or investors in all regions to fund more research. All these challenges are expected to be overcome and the market will show a high growth rate.
Technology Analysis
The major factor that will act as a lucrative growth factor for the opioids industry is the rise in acute diseases, awareness of serious health diseases, and surgeries. In the forecast period, the opioids market is expected to grow very rapidly due to increasing product approvals, research into removing or minimizing the side effects, and technological advancements.
Opioids Market Segment Insights
Products, drug class, indication, and distribution channel are the 4 factors of segmentation of the opioids market. The subdivision of these factors has been categorized as follow:
Opioids Market Product Insights
The major products that the opioids market is segmented into include oxycodone, codeine, morphine, hydrocodone, fentanyl, and methadone.
Opioids Market Drug Class Insights
The Drug Class constitutes opioids, COZ-2 inhibitors, nonsteroidal anti-inflammatory drugs, and others.
Opioids Market Indication Insights
Indication involves many reasons but a few that are the primary causes constitute inflammatory conditions, musculoskeletal pain, neuropathic pain, and cancer pain.
Opioids Market Distribution Channel Insights
The distribution of opioids is primarily done through two channels that are hospitals and retails pharmacies and online pharmacies with the advent of advancement and technology and the lucrative growth of online selling of medicinal drugs.
August 2023:Although the new Mu opioid receptors (MOR) agonists have potent anti-nociceptive effects, their propensity to develop physical dependency and tolerance raise severe concerns and restrict their usage. Recent studies have demonstrated that activating the opioid-related nociceptin receptor 1 (OPRL1), a recently identified branch of opioid receptors, can increase MOR agonist-induced analgesia while reducing tolerance and adverse effects.
Opioids Market Regional Insights
The world on a global basis is high on demands of opioid drugs leading to a lucrative growth of the opioids market. With a rise in cases of acute diseases at around 47.79%, North America dominates the opioids market share. The UK region however misuses and abuses it as compared to other regions. It is not recommended by experts and doctors to use opioids for a long period of time because it results in physical dependence, addiction, and other symptoms, hence it is advised to use them very carefully and under the supervision of a doctor and a practitioner. In Canada, the increase in cases of opioid drug overdose, strict government policies, and other things are preventing the growth of the opioid market.
Opioids are the fastest-growing drug market in the Asia Pacific. Many health care professionals and patients associate opioid use with stigmas such as addiction and other side effects. To deal with the situation, the Chinese government has launched a "good pain management" campaign. Cancer patients in China have benefitted from the use of these opioid drugs since 2011. The Middle East & Africa, as well as Europe, are among the many other regions that have a large market share for opioids.
Competitive Landscape
Opioids are a growing market, with strong players such as Allergan PLC, AbbVie Inc., Bayer, etc. Every year, there are new companies entering this market due to its rapid growth. These companies often introduce drugs that are technologically advanced. In their research, they continue to identify the best solution to minimize the negative effects and complications caused due to the use of opioids.
Companies that make opioids market share include
- Sanofi (France)
- Teva Pharmaceutical Industries (Israel)
- Bristol-Myers Squibb (US)
- AbbVie Inc. (US)
- Boehringer Ingelheim International GmbH (Germany)
- Purdue Pharma (US)
- Astellas Pharma Inc. (Japan)
- Pfizer Inc. (US)
- Astellas Pharma Inc (Japan)
- Biogen Idec (US)
- Bayer (Germany)
- GlaxoSmithKline (UK).
Recent Developments
August 2023, Emergent BioSolutions will introduce an over-the-counter version of its opioid overdose therapy Narcan. With the slogan "anyone can save a life," the company will emphasize the possibility that the medicine will keep loved ones safe. Maryland-based Narcan was given FDA approval by Emergent in March, and it is now a key component of the company's aspirations to become profitable again in August. The business recently increased its full-year prediction for Narcan sales, adding $65 million at the top and bottom end to expand the goal range to between $425 million and $445 million in response to variables such as the OTC launch.
November 2023 Purdue Pharma, the company responsible for OxyContin, releases its first quarterly financial report since emerging from bankruptcy. The report shows that the company is still struggling financially, but that it is making progress in paying off its debts and compensating victims of the opioid crisis.A new study by the Centers for Disease Control and Prevention (CDC) finds that the number of opioid overdose deaths in the United States decreased by 10% in 2022. This is the first decline in opioid overdose deaths in six years.The FDA announces that it is taking steps to make it more difficult for people to obtain prescriptions for opioids. These steps include requiring doctors to get more training on the risks of opioids and making it more difficult for people to get multiple prescriptions for opioids simultaneously.
October 2023 A new study published in the journal JAMA Network Open finds that a combination of two drugs, including a buprenorphine and naltrexone combination, is effective in reducing the risk of opioid overdose deaths. The study found that the combination of drugs was more effective than buprenorphine alone.Another study published in the journal Pain Medicine finds that a new type of implantable opioid overdose prevention device is effective in reducing the risk of opioid overdose deaths. The study found that the device was effective in preventing opioid overdose deaths in patients who were at high risk of overdose.The American Society of Addiction Medicine (ASAM) releases a new guideline on the use of buprenorphine for the treatment of opioid addiction. The guideline recommends that buprenorphine be used as the first-line treatment for opioid addiction in most patients.
September 2023 The US Department of Justice (DOJ) announces that it is suing three major opioid distributors, including McKesson, Cardinal Health, and AmerisourceBergen, for their role in the opioid crisis. The DOJ alleges that the companies knowingly distributed opioids to pharmacies that were diverting the drugs for illegal use.The FDA approves a new drug called naloxone rescue nasal spray for the treatment of opioid overdose. The drug is designed to be used by non-medical personnel, such as family members or friends of people who are at risk of opioid overdose.
The opioids market analysis report gives an inside and out an overview of the estimated and future growth of the opioids market. Each section includes a challenge, restraint, opportunity, COVID analysis, segment overview, driving forces, company listing, recent developments, and more. Additionally, it is useful to know which companies are supporting the growth of the opioids market with research and new products. The report gives a proper analysis for investors to make decisions before making lucrative investments in opioids market. Using both primary and secondary sources of information, the opioid market is forecasted to grow well during the forecast period globally and regionally.
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
